- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions

European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Paclitaxel (aqueous gel)
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Paclitaxel (aqueous gel)
| EU orphan designation number: | EU/3/10/846
|
| Active ingredient: | Paclitaxel (aqueous gel) |
| Indication: | Treatment of oesophagus carcinoma |
| Sponsor: | BTG plc
5 Fleet Place, London EC4M 7RD, United Kingdom |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 01/03/2011 | Orphan designation | EMA/OD/013/10 | (2011)1313 of 23/02/2011 |


